none18noneClaviez A; Canals C; Dierickx D; Stein J; Badell I; Pession A; Mackinnon S; Slavin S; Dalle JH; Chacón MJ; Sarhan M; Wynn RF; Suttorp M; Dini G; Sureda A; Schmitz N; Lymphoma and Pediatric Diseases Working Parties.Claviez A; Canals C; Dierickx D; Stein J; Badell I; Pession A; Mackinnon S; Slavin S; Dalle JH; Chacón MJ; Sarhan M; Wynn RF; Suttorp M; Dini G; Sureda A; Schmitz N; Lymphoma and Pediatric Diseases Working Parties
S u m m a r y B a c k g r o u n d. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is...
Access to hematopoietic stem cell transplantation (HSCT) in pediatric acute lymphoblastic leukemia (...
AbstractMore than 20% of allogeneic hematopoietic cell transplantations (HCTs) are performed in chil...
Ninety-one children and adolescents 18 years or younger after allogeneic hematopoietic stem cell tra...
40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation -- MAR 30-APR 02, 201...
Between 1995–2001 a total of 52 hematopoietic stem cells transplantations (HSCT) were performed in 5...
We examined the role of hematopoietic stem cell transplantation (HSCT) for patients aged≤18 years wi...
Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) still represents a major challenge. We ...
Despite poor survival, controversies remain in the treatment for refractory or relapsed pediatric no...
Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) still represents a major challenge. We ...
More than 20% of allogeneic hematopoietic cell transplantations (HCTs) are performed in children and...
More than 20\% of allogeneic hematopoietic cell transplantations (HCTs) are performed in children an...
Despite poor survival, controversies remain in the treatment for refractory or relapsed pediatric no...
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation -- APR 03-06, 2016 ...
More than 20% of allogeneic hematopoietic cell transplantations (HCTs) are performed in children and...
S u m m a r y B a c k g r o u n d. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is...
Access to hematopoietic stem cell transplantation (HSCT) in pediatric acute lymphoblastic leukemia (...
AbstractMore than 20% of allogeneic hematopoietic cell transplantations (HCTs) are performed in chil...
Ninety-one children and adolescents 18 years or younger after allogeneic hematopoietic stem cell tra...
40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation -- MAR 30-APR 02, 201...
Between 1995–2001 a total of 52 hematopoietic stem cells transplantations (HSCT) were performed in 5...
We examined the role of hematopoietic stem cell transplantation (HSCT) for patients aged≤18 years wi...
Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) still represents a major challenge. We ...
Despite poor survival, controversies remain in the treatment for refractory or relapsed pediatric no...
Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) still represents a major challenge. We ...
More than 20% of allogeneic hematopoietic cell transplantations (HCTs) are performed in children and...
More than 20\% of allogeneic hematopoietic cell transplantations (HCTs) are performed in children an...
Despite poor survival, controversies remain in the treatment for refractory or relapsed pediatric no...
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation -- APR 03-06, 2016 ...
More than 20% of allogeneic hematopoietic cell transplantations (HCTs) are performed in children and...
S u m m a r y B a c k g r o u n d. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is...
Access to hematopoietic stem cell transplantation (HSCT) in pediatric acute lymphoblastic leukemia (...
AbstractMore than 20% of allogeneic hematopoietic cell transplantations (HCTs) are performed in chil...